Howard B. Lieberman

4.3k total citations
73 papers, 3.5k citations indexed

About

Howard B. Lieberman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Howard B. Lieberman has authored 73 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 22 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Howard B. Lieberman's work include DNA Repair Mechanisms (42 papers), Cancer-related Molecular Pathways (17 papers) and Genomics and Chromatin Dynamics (12 papers). Howard B. Lieberman is often cited by papers focused on DNA Repair Mechanisms (42 papers), Cancer-related Molecular Pathways (17 papers) and Genomics and Chromatin Dynamics (12 papers). Howard B. Lieberman collaborates with scholars based in United States, United Kingdom and Canada. Howard B. Lieberman's co-authors include Kevin M. Hopkins, Constantinos G. Broustas, David J. Brenner, Tom K. Hei, Hongning Zhou, Charles R. Geard, Sally A. Amundson, Vladimir N. Ivanov, Evelyn M. Witkin and Aiping Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Howard B. Lieberman

72 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard B. Lieberman United States 34 2.6k 901 635 572 483 73 3.5k
Adayabalam S. Balajee United States 28 2.2k 0.9× 693 0.8× 662 1.0× 307 0.5× 323 0.7× 82 2.9k
Anne W. Hamburger United States 29 2.7k 1.1× 2.2k 2.5× 764 1.2× 515 0.9× 555 1.1× 110 4.9k
Hsing‐Jien Kung United States 36 2.1k 0.8× 1.1k 1.2× 939 1.5× 256 0.4× 921 1.9× 91 3.9k
Arrigo De Benedetti United States 39 4.1k 1.6× 667 0.7× 544 0.9× 261 0.5× 369 0.8× 94 4.8k
D Kufe United States 35 3.1k 1.2× 1.5k 1.6× 716 1.1× 559 1.0× 272 0.6× 78 4.7k
Amy Hutchinson United States 31 2.7k 1.0× 1.3k 1.4× 339 0.5× 478 0.8× 266 0.6× 73 4.5k
Uma Shankavaram United States 33 2.1k 0.8× 985 1.1× 950 1.5× 357 0.6× 508 1.1× 96 3.6k
Penelope A. Jeggo United Kingdom 23 3.1k 1.2× 872 1.0× 834 1.3× 247 0.4× 216 0.4× 33 3.6k
Razmik Mirzayans Canada 27 1.8k 0.7× 835 0.9× 666 1.0× 230 0.4× 247 0.5× 82 2.5k
Michiyuki Yamada Japan 32 2.4k 0.9× 713 0.8× 496 0.8× 396 0.7× 234 0.5× 65 4.2k

Countries citing papers authored by Howard B. Lieberman

Since Specialization
Citations

This map shows the geographic impact of Howard B. Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard B. Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard B. Lieberman more than expected).

Fields of papers citing papers by Howard B. Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard B. Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard B. Lieberman. The network helps show where Howard B. Lieberman may publish in the future.

Co-authorship network of co-authors of Howard B. Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard B. Lieberman. A scholar is included among the top collaborators of Howard B. Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard B. Lieberman. Howard B. Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Broustas, Constantinos G., et al.. (2020). Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents. Oncogene. 39(12). 2467–2477. 13 indexed citations
2.
Lieberman, Howard B., J. Alex, Richard A. Friedman, Kevin M. Hopkins, & Constantinos G. Broustas. (2018). Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management. Translational Cancer Research. 7(S6). S651–S661. 7 indexed citations
3.
Panigrahi, Sunil K., Kevin M. Hopkins, & Howard B. Lieberman. (2015). Regulation of NEIL1 protein abundance by RAD9 is important for efficient base excision repair. Nucleic Acids Research. 43(9). 4531–4546. 14 indexed citations
4.
Ghandhi, Shanaz A., Brian Ponnaiya, Sunil K. Panigrahi, et al.. (2014). RAD9 deficiency enhances radiation induced bystander DNA damage and transcriptomal response. Radiation Oncology. 9(1). 206–206. 16 indexed citations
5.
Vasileva, Ana, et al.. (2013). Clamping down on mammalian meiosis. Cell Cycle. 12(19). 3135–3334. 11 indexed citations
6.
Vasileva, Ana, Kevin M. Hopkins, Xiangyuan Wang, et al.. (2013). The DNA damage checkpoint protein RAD9A is essential for male meiosis in the mouse. Journal of Cell Science. 126(Pt 17). 3927–38. 23 indexed citations
7.
Broustas, Constantinos G., Aiping Zhu, & Howard B. Lieberman. (2012). Rad9 Protein Contributes to Prostate Tumor Progression by Promoting Cell Migration and Anoikis Resistance. Journal of Biological Chemistry. 287(49). 41324–41333. 33 indexed citations
8.
Lieberman, Howard B., Joshua D. Bernstock, Constantinos G. Broustas, et al.. (2011). The role of RAD9 in tumorigenesis. Journal of Molecular Cell Biology. 3(1). 39–43. 38 indexed citations
9.
Broustas, Constantinos G. & Howard B. Lieberman. (2011). Contributions of Rad9 to tumorigenesis. Journal of Cellular Biochemistry. 113(3). 742–751. 30 indexed citations
10.
Kleiman, Norman J., Carl D. Elliston, Kevin M. Hopkins, et al.. (2007). Mrad9 and Atm Haploinsufficiency Enhance Spontaneous and X-Ray-Induced Cataractogenesis in Mice. Radiation Research. 168(5). 567–573. 44 indexed citations
11.
Worgul, Basil V., Howard B. Lieberman, Lubomir B. Smilenov, et al.. (2006). Genetic Susceptibility to Radiation Cataractogenesis. Investigative Ophthalmology & Visual Science. 47(13). 4737–4737. 1 indexed citations
12.
Lieberman, Howard B.. (2005). Rad9, an evolutionarily conserved gene with multiple functions for preserving genomic Integrity. Journal of Cellular Biochemistry. 97(4). 690–697. 52 indexed citations
13.
Loegering, David A., Sonnet J.H. Arlander, Jennifer S. Hackbarth, et al.. (2004). Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death. Journal of Biological Chemistry. 279(18). 18641–18647. 33 indexed citations
14.
Roos‐Mattjus, Pia, Kevin M. Hopkins, Andrea J. Oestreich, et al.. (2003). Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling. Journal of Biological Chemistry. 278(27). 24428–24437. 95 indexed citations
15.
Sawant, Satin G., Wei Zheng, Kevin M. Hopkins, et al.. (2002). The Radiation-Induced Bystander Effect for Clonogenic Survival. Radiation Research. 157(4). 361–364. 69 indexed citations
16.
17.
Miyashita, Toshiyuki, Kevin M. Hopkins, Wei Zheng, et al.. (1999). Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nature Cell Biology. 2(1). 1–6. 124 indexed citations
18.
Hang, Haiying, et al.. (1998). Molecular cloning and tissue-specific expression ofMrad9, a murine orthologue of theSchizosaccharomyces pombe rad9+ checkpoint control gene. Journal of Cellular Physiology. 177(2). 241–247. 12 indexed citations
19.
Zhao, Yuqi, et al.. (1994). A new shuttle vector system for the identification of spontaneous and radiation-induced mutations in the fission yeast Schizosaccharomyces pombe. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 311(1). 111–123. 4 indexed citations
20.
Gerlach, Herwig, Howard B. Lieberman, R Bach, et al.. (1989). Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.. The Journal of Experimental Medicine. 170(3). 913–931. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adayabalam S. Balajee Breakdown of academic impact, for papers by Anne W. Hamburger Breakdown of academic impact, for papers by Hsing‐Jien Kung Breakdown of academic impact, for papers by Arrigo De Benedetti Breakdown of academic impact, for papers by D Kufe Breakdown of academic impact, for papers by Amy Hutchinson Breakdown of academic impact, for papers by Uma Shankavaram Breakdown of academic impact, for papers by Penelope A. Jeggo Breakdown of academic impact, for papers by Razmik Mirzayans Breakdown of academic impact, for papers by Michiyuki Yamada
Rankless by CCL
2026